Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease

E-ISSN： 1875-5828|12|1|32-46

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.12, Iss.1, 2015-01, pp. : 32-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

By Donahue John Flaherty Stephanie Johanson Conrad Duncan John Silverberg Gerald Miller Miles Tavares Rosemarie Yang Wentian Wu Qian Sabo Edmond Hovanesian Virginia Stopa Edward

Acta Neuropathologica, Vol. 112, Iss. 4, 2006-10 ,pp. : 405-415

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Trichostatin A on Gelsolin Levels, Proteolysis of Amyloid Precursor Protein, and Amyloid Beta-Protein Load in the Brain of Transgenic Mouse Model of Alzheimer's Disease

Current Alzheimer Research, Vol. 11, Iss. 10, 2014-12 ,pp. : 1002-1011

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid

By Verdile Giuseppe Gandy Samuel Martins Ralph

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 609-623

Springer Publishing Company

Access to resources Recommend Favorite

Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer's Disease

By Oh Esther

NeuroMolecular Medicine, Vol. 10, Iss. 3, 2008-09 ,pp. : 195-207

Humana Press, Inc

Access to resources Recommend Favorite

Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer,s Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?

Current Alzheimer Research, Vol. 13, Iss. 4, 2016-04 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite